Xact Kapitalforvaltning AB Sells 1,247 Shares of Intuitive Surgical, Inc. (ISRG)

Xact Kapitalforvaltning AB lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% in the 3rd quarter, HoldingsChannel reports. The fund owned 21,214 shares of the medical equipment provider’s stock after selling 1,247 shares during the period. Xact Kapitalforvaltning AB’s holdings in Intuitive Surgical were worth $12,177,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Jag Capital Management LLC boosted its stake in shares of Intuitive Surgical by 27.3% during the 3rd quarter. Jag Capital Management LLC now owns 32,438 shares of the medical equipment provider’s stock worth $18,619,000 after purchasing an additional 6,955 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH boosted its stake in shares of Intuitive Surgical by 37.6% during the 3rd quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 3,927 shares of the medical equipment provider’s stock worth $2,225,000 after purchasing an additional 1,073 shares during the period. Chevy Chase Trust Holdings Inc. boosted its position in shares of Intuitive Surgical by 2.8% during the third quarter. Chevy Chase Trust Holdings Inc. now owns 193,091 shares of the medical equipment provider’s stock valued at $110,834,000 after buying an additional 5,279 shares during the period. Sigma Investment Counselors Inc. boosted its position in shares of Intuitive Surgical by 10.8% during the third quarter. Sigma Investment Counselors Inc. now owns 3,731 shares of the medical equipment provider’s stock valued at $2,142,000 after buying an additional 365 shares during the period. Finally, Calamos Advisors LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $6,299,000. Institutional investors own 84.83% of the company’s stock.

In related news, Director Mark J. Rubash sold 150 shares of the company’s stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $543.66, for a total value of $81,549.00. Following the completion of the sale, the director now directly owns 4,116 shares of the company’s stock, valued at $2,237,704.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Marshall Mohr sold 8,250 shares of the company’s stock in a transaction dated Monday, July 30th. The stock was sold at an average price of $508.50, for a total transaction of $4,195,125.00. Following the completion of the sale, the vice president now directly owns 18,071 shares of the company’s stock, valued at $9,189,103.50. The disclosure for this sale can be found here. Insiders sold a total of 83,753 shares of company stock valued at $42,966,655 over the last quarter. Company insiders own 2.20% of the company’s stock.



Several research analysts have issued reports on the company. BTIG Research restated a “hold” rating on shares of Intuitive Surgical in a research report on Sunday, October 21st. Royal Bank of Canada restated a “hold” rating and set a $560.00 target price on shares of Intuitive Surgical in a research report on Friday, October 19th. Raymond James boosted their price objective on Intuitive Surgical from $620.00 to $630.00 and gave the company an “outperform” rating in a report on Friday, October 19th. Piper Jaffray Companies boosted their price objective on Intuitive Surgical to $613.00 and gave the company an “overweight” rating in a report on Friday, October 19th. Finally, Canaccord Genuity upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and boosted their price objective for the company from $550.00 to $610.00 in a report on Friday, October 19th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seventeen have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $554.01.

Shares of NASDAQ ISRG opened at $492.92 on Friday. The company has a market capitalization of $58.17 billion, a P/E ratio of 68.56, a PEG ratio of 3.50 and a beta of 0.89. Intuitive Surgical, Inc. has a 52-week low of $359.75 and a 52-week high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.66 by $0.17. The firm had revenue of $920.90 million during the quarter, compared to analyst estimates of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. Intuitive Surgical’s quarterly revenue was up 14.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.77 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 9.35 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Featured Story: How a Put Option Works

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply